Therapy-related orbital myeloid sarcoma is very rare ([@B1]). A 61-year-old woman was admitted because of protrusion of the right eyeball ([Picture 1](#g001){ref-type="fig"}). Computed tomography revealed a mass lesion in the right orbit that showed the uptake of ^18^F-fluorodeoxyglucose on positron emission tomography ([Picture 2](#g002){ref-type="fig"}). A biopsy of the right orbit mass revealed proliferation of atypical cells that were positive for myeloperoxidase ([Picture 3](#g003){ref-type="fig"}). A bone marrow examination showed neither an increase in blasts nor myelodysplasia. A diagnosis of myeloid sarcoma confined to the right orbit was made. She had a history of ovarian carcinoma treated with irinotecan and cisplatin 10 years earlier, so her disease was classified as therapy-related myeloid neoplasm ([@B2]). She received remission-induction chemotherapy for acute myeloid leukemia (idarubicin plus cytarabine) followed by a consolidation radiotherapy toward the right orbit. After the treatment, the protrusion of the right eyeball was markedly improved ([Picture 4](#g004){ref-type="fig"}).
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